176 related articles for article (PubMed ID: 34817207)
1. Garlic: An Alternative Treatment for Group B Streptococcus.
Torres KAM; Lima SMRR; Torres LMB; Gamberini MT; Silva Junior PID
Microbiol Spectr; 2021 Dec; 9(3):e0017021. PubMed ID: 34817207
[TBL] [Abstract][Full Text] [Related]
2. Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance.
Khan MA; Faiz A; Ashshi AM
Ann Saudi Med; 2015; 35(6):423-7. PubMed ID: 26657224
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic Susceptibility Patterns and Prevalence of Streptococcus Agalactiae Rectovaginal Colonization Among Pregnant Women in Iran.
Dashtizade M; Zolfaghari MR; Yousefi M; Nazari-Alam A
Rev Bras Ginecol Obstet; 2020 Aug; 42(8):454-459. PubMed ID: 32559790
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, antimicrobial susceptibility patterns, serotypes and risk factors for group B streptococcus rectovaginal isolates among pregnant women at Kenyatta National Hospital, Kenya; a cross-sectional study.
Jisuvei SC; Osoti A; Njeri MA
BMC Infect Dis; 2020 Apr; 20(1):302. PubMed ID: 32321444
[TBL] [Abstract][Full Text] [Related]
5. [Serotypes and antibiotic resistance patterns in beta-hemolytic Streptococcus agalactiae isolates in colonized mothers and newborns with invasive disease].
Liébana-Martos Mdel C; Cabrera-Alavargonzalez J; Rodríguez-Granger J; Miranda-Casas C; Sampedro-Martínez A; Gutiérrez-Fernández J; Rosa-Fraile M; Navarro-Marí JM
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):84-8. PubMed ID: 25542335
[TBL] [Abstract][Full Text] [Related]
6. ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED FROM PREGNANT WOMEN.
Melo SC; Santos NC; Oliveira M; Scodro RB; Cardoso RF; Pádua RA; Silva FT; Costa AB; Carvalho MD; Pelloso SM
Rev Inst Med Trop Sao Paulo; 2016 Nov; 58():83. PubMed ID: 27828624
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci.
Cutler RR; Odent M; Hajj-Ahmad H; Maharjan S; Bennett NJ; Josling PD; Ball V; Hatton P; Dall'Antonia M
J Antimicrob Chemother; 2009 Jan; 63(1):151-4. PubMed ID: 19001449
[TBL] [Abstract][Full Text] [Related]
8. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis.
Gizachew M; Tiruneh M; Moges F; Adefris M; Tigabu Z; Tessema B
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):3. PubMed ID: 30660188
[TBL] [Abstract][Full Text] [Related]
9. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study.
Crespo-Ortiz Mdel P; Castañeda-Ramirez CR; Recalde-Bolaños M; Vélez-Londoño JD
BMC Infect Dis; 2014 Aug; 14():428. PubMed ID: 25086463
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B Streptococci isolates among pregnant women in Jimma, Ethiopia.
Mengist A; Kannan H; Abdissa A
BMC Res Notes; 2016 Jul; 9():351. PubMed ID: 27435469
[TBL] [Abstract][Full Text] [Related]
11. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
12. The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women.
Mukesi M; Iweriebor BC; Obi LC; Nwodo UU; Moyo SR; Okoh AI
BMC Complement Altern Med; 2019 Jan; 19(1):34. PubMed ID: 30700288
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and serotype distribution of Streptococcus agalactiae rectovaginal colonising isolates from pregnant women at a tertiary hospital in Pretoria, South Africa: An observational descriptive study.
Said M; Dangor Y; Mbelle N; Madhi SA; Kwatra G; Ismail F
S Afr Med J; 2020 Aug; 110(9):869-871. PubMed ID: 32880270
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial resistance and molecular characterization of Streptococcus agalactiae from pregnant women in southern China.
Guo H; Fu M; Peng Q; Chen Z; Liu J; Qiu Y; Huang Y
J Infect Dev Ctries; 2019 Sep; 13(9):802-809. PubMed ID: 32074089
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the antibacterial activities of radezolid and linezolid for Streptococcus agalactiae.
Zheng JX; Chen Z; Xu ZC; Chen JW; Xu GJ; Sun X; Yu ZJ; Qu D
Microb Pathog; 2020 Feb; 139():103866. PubMed ID: 31715321
[TBL] [Abstract][Full Text] [Related]
16. Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia.
Ali MM; Woldeamanuel Y; Asrat D; Fenta DA; Beall B; Schrag S; McGee L
BMC Infect Dis; 2020 Nov; 20(1):848. PubMed ID: 33198686
[TBL] [Abstract][Full Text] [Related]
17. Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples.
Mudzana R; Mavenyengwa RT; Gudza-Mugabe M
BMC Infect Dis; 2021 Jan; 21(1):125. PubMed ID: 33509097
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial activity of zinc against group B Streptococcus is strain-dependent across diverse sequence types, capsular serotypes, and invasive versus colonizing isolates.
Francis JD; Guevara MA; Lu J; Madhi SA; Kwatra G; Aronoff DM; Manning SD; Gaddy JA
BMC Microbiol; 2022 Jan; 22(1):23. PubMed ID: 35026981
[TBL] [Abstract][Full Text] [Related]
19. [Do we need a different approach to GBS screening?].
Szymusik I; Kosińska-Kaczyińska K; Pietrzak B; Wielgoś M
Ginekol Pol; 2014 Jun; 85(6):456-60. PubMed ID: 25029812
[TBL] [Abstract][Full Text] [Related]
20. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
